SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Medical Oncology (genitourinary) Referral — Pablo Neruda

PatientPablo Neruda
Date of birth1959-07-12
IdentifiersMRN HR-ML051-SYN; SSN (made up) 000-51-2976
Document date2026-06-01
AuthorMarisol Fairweather-Diaz, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Man of 66 with four months of urinary symptoms and six weeks of right hip and low back pain, a hard nodular prostate, PSA 46.8 ng/mL and a raised alkaline phosphatase: suspected metastatic prostate cancer. Please confirm the diagnosis and extent and advise on treatment, including bone health and genetic testing. [S]

Urgency: Urgent, within two weeks. [S]

Questions for the consultant:

History of Present Illness

Poet and diplomat, posted abroad; Spanish is his first language and a professional interpreter is used. Four months of frequency, weak stream and nocturia three times (IPSS 17); six weeks of aching right buttock and hip pain and low back pain, worse at night, pain 6 of 10. No leg weakness, numbness, or change in bladder or bowel control. Digital rectal examination: hard, nodular right lobe with loss of the right lateral border. Hypertension for five years on amlodipine 5 mg; blood pressure 146/88 mm Hg today. Never smoker. Laboratory tests today: PSA 46.8 ng/mL, testosterone 468 ng/dL, hemoglobin 13.6 g/dL, creatinine 0.96 mg/dL, calcium 9.6 mg/dL, alkaline phosphatase 168 U/L, LDH 208 U/L, hemoglobin A1c 5.9 percent, LDL 140 mg/dL, 25-hydroxyvitamin D 22 ng/mL. PHQ-9 score 6. MRI of the prostate, a targeted biopsy at the urology practice, CT of the chest, abdomen and pelvis, a bone scan and PSMA PET/CT are being arranged before your visit. Acetaminophen started for pain [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

9 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route2021-04-06 to 2026-07-13completedS
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) up to three times daily as needed for bone painTwo tablets up to three times daily as neededOral route2026-06-01 to 2026-09-14completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Urinary frequency, weak stream and nocturia for four months, with right hip and low back pain for six weeks, a hard nodular prostate and a raised PSA; suspected prostate cancer, to be confirmedactiveconfirmed R97.20S — Synthetic presenting problem, resolved at the second visit when biopsy and staging established metastatic prostate cancer.
Essential hypertension for five years, on amlodipineactiveconfirmed I10S — Synthetic comorbidity, relevant to cardiovascular risk on androgen deprivation; not a claim about his real blood pressure.
Prediabetes (hemoglobin A1c 5.9%)activeconfirmed R73.03S — Synthetic metabolic finding at intake, relevant to androgen deprivation.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

No historical medical events are recorded.

Family History

RelativeConditionAge at deathEvidence
motherDied shortly after his birth; cause not recorded in the cited sourceD (CLM-0001)

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-06-01Body height178cmS
2026-06-01Body weight92.4kgS
2026-06-01Body mass index (BMI) [Ratio]29.2kg/m2S
2026-06-01Systolic blood pressure146mm[Hg]S
2026-06-01Diastolic blood pressure88mm[Hg]S
2026-06-01Heart rate76/minS
2026-06-01Respiratory rate14/minS
2026-06-01Body temperature36.7CelS
2026-06-01Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-01Prostate specific Ag [Mass/volume] in Serum or Plasma46.8ng/mL<=4 ng/mLHighS
2026-06-01Testosterone [Mass/volume] in Serum or Plasma468ng/dL264 to 916 ng/dL in adult men; below 50 ng/dL is the castrate target on androgen deprivationNormalS
2026-06-01Hemoglobin [Mass/volume] in Blood13.6g/dL13.2-16.6 g/dLNormalS
2026-06-01Leukocytes [#/volume] in Blood by Automated count6.410*3/uL4-11 10*3/uLNormalS
2026-06-01Platelets [#/volume] in Blood by Automated count24810*3/uL150-400 10*3/uLNormalS
2026-06-01Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-06-01Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-06-01Glucose [Mass/volume] in Serum or Plasma104mg/dL70-99 mg/dLHighS
2026-06-01Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.74-1.35 mg/dLNormalS
2026-06-01Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-01Calcium [Mass/volume] in Serum or Plasma9.6mg/dL8.6-10.3 mg/dLNormalS
2026-06-01Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-55 U/LNormalS
2026-06-01Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L8-48 U/LNormalS
2026-06-01Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma168U/L40-129 U/LHighS
2026-06-01Albumin [Mass/volume] in Serum or Plasma4.1g/dL3.5-5 g/dLNormalS
2026-06-01Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma208U/L135-225 U/LNormalS
2026-06-01Hemoglobin A1c/Hemoglobin.total in Blood5.9%<=5.6%HighS
2026-06-01Cholesterol [Mass/volume] in Serum or Plasma214mg/dL<=199 mg/dLHighS
2026-06-01Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
2026-06-01Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation140mg/dL<=129 mg/dLHighS
2026-06-01Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
2026-06-0125-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma22ng/mL30-100 ng/mLLowS
2026-06-01Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-06-01International Prostate Symptom Score [IPSS]17{score}S
2026-06-01Pain severity - 0-10 verbal numeric rating [Score] - Reported6{score}S

Assessment

Plan of Treatment